ENCANTO Consortium Secures Full Regulatory Approval and Initiates Patient Recruitment

The ENCANTO Consortium today announced the successful achievement of full regulatory approval across all participating countries, a decisive step forward in advancing its pioneering clinical program. With this approval, ENCANTO …

The ENCANTO project, a Horizon Europe–funded clinical initiative focused on innovative cartilage regeneration for osteoarthritis patients, has officially launched its presence across key social media platforms. With the goal of …

As part of its communication and outreach efforts, the ENCANTO project has launched a newly designed flyer and infographic to introduce its groundbreaking N-TEC therapy to a broader audience. These …

The ENCANTO project held its 3rd General Assembly on May 7–8, 2025, at Dubrovnik, Croatia. The two-day meeting brought together clinical partners, researchers, and coordinators from across Europe to align …